Content about Investment banks

November 15, 2013

The management team of Tops Friendly Markets has purchased the chain from the private equity firm that owned it, according to published reports.

NEW YORK — The management team of Tops Friendly Markets has purchased the chain from the private equity firm that owned it, according to published reports.

The Rochester, N.Y., Democrat & Chronicle reported Friday that Tops CEO Frank Curci and five other executives were buying the chain from Morgan Stanley Capital Partners, which has owned the chain since 2007. Tops operates 155 stores in upstate New York, western Vermont and northern Pennsylvania under the Tops, Grand Union and Bryant's banners.

November 7, 2013

According to a Credit Suisse analysis of the drug channel published Wednesday, drug stores are in for a challenging winter across the front-end with an embattled consumer continuing to hold back and the continued proliferation of dollar stores that are attracting value-driven trips to their channel.

NEW YORK — According to a Credit Suisse analysis of the drug channel published Wednesday, drug stores are in for a challenging winter across the front-end with an embattled consumer continuing to hold back and the continued proliferation of dollar stores that are attracting value-driven trips to their channel. 

July 22, 2013

Front-end drug store sales are weakening, Credit Suisse reported in a research note.

NEW YORK — Front-end drug store sales are weakening, Credit Suisse reported Monday morning in a research note. 

April 8, 2013

Blackhawk Network Holdings announced its intent to open its initial public offering of 10 million shares at an estimated offering price of $20 to $22 per share.

PLEASANTON, Calif. — Blackhawk Network Holdings on Monday announced its intent to open its initial public offering of 10 million shares at an estimated offering price of $20 to $22 per share. The IPO will consist solely of shares to be offered by existing stockholders, including Safeway, and could raise as much as $220 million. 

March 20, 2013

Generic drug maker Sagent Pharmaceuticals has appointed James Hussey as its president, the company said.

SCHAUMBURG, Ill. — Generic drug maker Sagent Pharmaceuticals has appointed James Hussey as its president, the company said.

Sagent said the board of directors' appointment of Hussey, 53, would be effective Monday. Hussey will be responsible for the company's commercial operations, including development, regulatory affairs, supply chain activities, sales, marketing and human resources.

February 15, 2013

The Vitamin Shoppe announced that it has closed on the previously announced purchase of Super Supplements — a specialty retailer of vitamins, minerals and supplements — for approximately $50 million.

NORTH BERGEN, N.J. — The Vitamin Shoppe on Thursday announced that it has closed on the previously announced purchase of Super Supplements — a specialty retailer of vitamins, minerals and supplements — for approximately $50 million.  

Super Supplements is headquartered in Seattle and operates 31 stores in the Pacific Northwest.

December 12, 2012

Markwins announced on Wednesday that it has acquired all of the outstanding securities of Physicians Formula for $75 million or $4.90 per share in cash.

CITY OF INDUSTRY and AZUSA, Calif. — Markwins announced on Wednesday that it has acquired all of the outstanding securities of Physicians Formula for $75 million or $4.90 per share in cash.

September 11, 2012

Walgreens on Monday announced that it has priced an underwritten public offering of senior notes.

DEERFIELD, Ill. — Walgreens on Monday announced that it has priced an underwritten public offering of senior notes, the net proceeds from which will be used to repay — in full — money that was borrowed to fund the cash consideration in its acquisition of a 45% stake in Alliance Boots and for general corporate purposes, including its previously announced USA Drug acquisition.

The senior notes consist of:

  • $550 million of floating rate notes due 2014;

  • $750 million of 1% notes due 2015;

March 14, 2012

Grocer A&P has emerged from bankruptcy as a privately held company.

MONTVALE, N.J. — Grocer A&P has emerged from bankruptcy as a privately held company.

As previously announced, Mount Kellett Capital Management, The Yucaipa Cos. and investment funds managed by Goldman Sachs Asset Management, have provided $490 million in debt and equity financing to sponsor A&P’s reorganization plan and complete its balance sheet restructuring. In addition, JP Morgan and Credit Suisse arranged a $645 million exit financing facility.

January 3, 2012

Retailers will report weak December front-end sales growth across the drug channel as continued inflation likely was offset by the slow start to the flu season and disappointing overall traffic and volume growth, Credit Suisse research analyst Ed Kelly suggested in a note published Tuesday.

NEW YORK — Retailers will report weak December front-end sales growth across the drug channel as continued inflation likely was offset by the slow start to the flu season and disappointing overall traffic and volume growth, Credit Suisse research analyst Ed Kelly suggested in a note published Tuesday.

"While drug stores have been fairly successful passing through product cost inflation at the shelf, our Nielsen Trend Tracker shows that volumes have decelerated in recent months given the weak consumer and normal price elasticity," he wrote.

August 30, 2011

Jonathon Singer has been appointed CFO of Sagent Pharmaceuticals, the generic drug maker said.

SCHAUMBURG, Ill. — Jonathon Singer has been appointed CFO of Sagent Pharmaceuticals, the generic drug maker said.

Singer joins Sagent from Landauer, a leader in radiation sciences and services, where he served as SVP finance and CFO. Meanwhile, Sagent's current CFO, Ron Pauli, will be transitioned into a newly created role of chief business officer, where he will be responsible for product launch execution, product pipeline management and business development.

April 1, 2011

GNC Thursday evening announced its initial public offering of 22.5 million shares of its Class A common stock at an opening price of $16 per share.

PITTSBURGH — GNC Thursday evening announced its initial public offering of 22.5 million shares of its Class A common stock at an opening price of $16 per share.

Of the shares offered, 16 million are being issued and sold by GNC and 6.5 million shares are being sold by selling stockholders.

In addition, selling stockholders have granted the underwriters a 30-day option to purchase up to an additional 3.4 million shares. That offering is expected to close on April 6.

March 21, 2011

Following the recent sale of Walgreens' pharmacy benefit management business, Credit Suisse analysts said they are interested in the executive team's updated thinking on their healthcare strategy and plans for the $550 million in proceeds.

NEW YORK — Following the recent sale of Walgreens' pharmacy benefit management business, Credit Suisse analysts said they are interested in the executive team's updated thinking on their healthcare strategy and plans for the $550 million in proceeds.

October 5, 2010

Generic drug maker Sagent Pharmaceuticals has launched two injectable antibiotics, the company said Tuesday....

SCHAUMBURG, Ill. Generic drug maker Sagent Pharmaceuticals has launched two injectable antibiotics, the company said Tuesday.

 

Sagent announced the launch of ampicillin and ampicillin with sulbactam. Ampicillin had sales of around $42 million during the 12-month period ended in June, while ampicillin with sulbactam had sales of around $40 million during the same period, according to IMS Health.

 

 

May 9, 2010

Actavis and Sagent Pharmaceuticals have agreed to develop and market a group of injectable drugs...